We Experience: Perspectives on a Quality Abortion Care Experience: A Patient Centered Approach
NCT ID: NCT02827474
Last Updated: 2018-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
34 participants
OBSERVATIONAL
2016-07-31
2018-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determinants of Success, Characterizing the Facilitators of Integrated Abortion Provision
NCT03181061
Developing and Testing Interventions to Address Conscientious Objection to Abortion Care in Mexico and South Africa
NCT04290832
Feasibility of Telemedicine Medical Abortion
NCT04599725
Chart Review Study of Medical Abortion
NCT02841072
Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion
NCT00994734
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will conduct semi-structured interviews with patient participants and providers separately to determine patients' expectations of abortion care as well as the most important aspects of the abortion experience and to explore providers' perceptions of their patients' abortion experience and assess concordance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient Participants
Patient participants will participate in two patient interviews.
Patient Interview
Patient intervention includes a 30 minute interview prior to their abortion procedure and a follow up phone-interview that will be 10-minutes and held 24-72 hours from the procedure.
Physician Participants
Provider participants will participate in one provider interview.
Provider Interview
For physician participants, providers will be interviewed after completion of the patient's visit and this will be 10-15 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patient Interview
Patient intervention includes a 30 minute interview prior to their abortion procedure and a follow up phone-interview that will be 10-minutes and held 24-72 hours from the procedure.
Provider Interview
For physician participants, providers will be interviewed after completion of the patient's visit and this will be 10-15 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women ages 18-45 years.
* Woman must have a completed surgical abortion procedure
* Women must be able to speak English or Spanish.
Exclusion Criteria
* Women who are unable to consent and/or are cognitively impaired.
* Women who are under the age of 18
* Women who are incarcerated.
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of New Mexico
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brenda Pereda
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brenda Pereda, MD
Role: PRINCIPAL_INVESTIGATOR
University on New Mexico
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Reproductive Health
Albuquerque, New Mexico, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UNMHSC- 16-111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.